Posted on: 26 April, 2021
A team of researchers from the Kolling Institute, The University of Sydney, Monash University and La Trobe University have led a global call to action to accelerate new approaches for cardiovascular disease (CVD) drug solutions.
CVD is the leading cause of death globally. Since the start of the pandemic approximately 18 million people have died of CVD, with the majority from low- and middle-income .....
Read more
Category: Cardiovascular and Renal Research
Posted on: 23 April, 2021
Treatment of whiplash injuries may be modified following research which has found even minor motor vehicle accidents can cause a long-term spinal cord injury.
Researchers from the Kolling Institute along with scientists from Northwestern, Stanford and the University of Oklahoma conducted the longitudinal study involving participants who had been involved in a relatively simple rear-end motor vehicl.....
Read more
Category: Musculoskeletal Research
Posted on: 21 April, 2021
Doctors and researchers are increasingly concerned at the steady rise in premature twin births in New South Wales.
Professor Jonathan Morris and his team from the Kolling’s Women and Babies Research group analysed over 14,000 twin pregnancies from 2003-2014, finding 49 per cent of twins were born premature before 37 weeks, and 69 per cent of all births were planned either by pre-labour caesarean or.....
Read more
Category: Research Excellence
Posted on: 14 April, 2021
Two of our leading researchers will drive key Australian projects following a funding announcement from the National Health and Medical Research Council. (NHMRC)
More than $1.4 million from the partnership grant program will go to Kolling researcher and RNSH interventional cardiologist Professor Gemma Figtree and her team for a study to reduce coronary artery disease. The world-first project will r.....
Read more
Category: Cardiovascular and Renal Research
Posted on: 23 February, 2021
Related links
See Our New Research Strategy
Download Our Research Strategy
Support Us
Read more
Category: Research Excellence
Posted on: 23 February, 2021
Related links
See Our New Research Strategy
Download Our Research Strategy
Support Us
Read more
Category: Research Excellence
Posted on: 14 December, 2020
Kolling researcher and Royal North Shore Hospital cardiologist Dr Rebecca Kozor will lead a world-first study using MRI technology to improve the diagnosis of heart failure.
The trial has been made possible following a $50,000 Cardiac Society of Australia and New Zealand-Boehringer Ingelheim innovation grant.
Dr Kozor has welcomed the funding to quantify pulmonary congestion or lung water density i.....
Read more
Category: Cardiovascular and Renal Research, Funding support
Posted on: 14 December, 2020
The Kolling’s Women and Babies Research team is calling for a reduction in the number of early births, with the latest research highlighting the benefits of labour as close to 40 weeks as possible.
Twenty years ago, the majority of women gave birth at 40 weeks. Today it’s between 38 and 39 weeks and continuing to get earlier.
This trend is due to the growing number of planned early births at 36, 37.....
Read more
Category: Cardiovascular and Renal Research, Research Excellence
Posted on: 10 December, 2020
The Kolling’s Dr Amanda Hudson will lead an exciting pilot study after being awarded an innovation grant by the Mark Hughes Foundation for brain cancer research.
The Bill Walsh Lab scientist is one of a select group to have received funding from the foundation. Her research will now investigate the early detection of disease progression in brain cancer.
Dr Hudson said identifying changes in tumour .....
Read more
Category: Funding support, Neuroscience and Pain Research
Posted on: 10 December, 2020
Congratulations to Kolling cancer researcher and Sydney Vital fellow Dr Yaser Hadi Gholami on being awarded the prestigious 2020 Physics Grand Challenges grant.
The Grand Challenges project was initiated by the University of Sydney’s School of Physics to drive new discoveries and breakthroughs that will transform the world.
$250,000 will be directed to Dr Gholami’s innovative research which aims to.....
Read more
Category: Funding support